GovHealthInfo.com: Diseases and Conditions

GovHealthInfo > Diseases and Conditions > Alopecia

This article provides summary information pertaining to the disease / condition of Alopecia. This information was extracted from selected U.S. Government resources. Links to related conditions are also provided.

healthfinder.gov — National Alopecia Areata Foundation - NAAF
The National Alopecia Areata Foundation (NAAF) was established in 1981 as a support network for people who have this disorder, to disseminate information about it, and to raise funds for research. The Foundation provides information on Alopecia areata, including suggestions for coping with it, cosmetically and psychologically; NAAF can also provide the names of local support groups. It is supported through donations.

MedlinePlus Medical Encyclopedia: Alopecia areata
The primary symptom of Alopecia areata is roundish patches of hair loss on the head, with smooth, hairless scalp in the affected areas. Alopecia totalis involves the complete loss of all scalp hair, and Alopecia universalis is characterized by the complete loss of all scalp and body hair.

Q&A Alopecia Areata
The key to coping is valuing yourself for who you are, not for how much hair you have or don't have. Many people learning to cope with Alopecia areata find it helpful to talk with other people who are dealing with the same problems. More than four million people nationwide have this disease at some point in their lives, so you are not alone. If you would like to be in touch with others with the disease, the National Alopecia Areata Foundation (NAAF) can help through its pen pal program, message boards, annual conference, and support groups that meet in various locations nationwide. To find contact information for NAAF and other organizations that can help people with Alopecia areata, see "Where Can I Learn More About Alopecia Areata?" .

Questions and Answers About Alopecia Areata
The key to coping is valuing yourself for who you are, not for how much hair you have or don't have. Many people learning to cope with Alopecia areata find it helpful to talk with other people who are dealing with the same problems. More than four million people nationwide have this disease at some point in their lives, so you are not alone. If you would like to be in touch with others with the disease, the National Alopecia Areata Foundation (NAAF) can help through its pen pal program, message boards, annual conference, and support groups that meet in various locations nationwide. To find contact information for NAAF and other organizations that can help people with Alopecia areata, see "Where Can I Learn More About Alopecia Areata?" .

Androgenetic alopecia - Genetics Home Reference
Androgenetic Alopecia in men has been associated with several other medical conditions including coronary heart disease and enlargement of the prostate, a walnut-sized gland in males that is located below the bladder. Additionally, prostate cancer, disorders of insulin resistance (such as diabetes and obesity), and high blood pressure (hypertension) have been related to androgenetic Alopecia. In women, androgenetic Alopecia is associated with an increased risk of polycystic ovary syndrome (PCOS). PCOS is characterized by a hormonal imbalance that can lead to irregular menstruation, acne, excess body hair (hirsutism), and weight gain.

Guidelines for the management of alopecia areata.
An explanation of Alopecia areata, including discussion of the nature and course of the disease and the available treatments, is essential. Some patients are profoundly upset by their Alopecia and may require psychological support. Contact with other sufferers and patient support groups may help patients adjust to their disability. The decision to treat Alopecia areata actively should not be taken lightly. Treatment can be uncomfortable for the patient, time consuming and potentially toxic. It may also alter the patient's attitude to their hair loss. Some patients find it difficult to cope with relapse following or during initially successful treatment and they should be forewarned of this possibility. These considerations are particularly important in children where the social disruption and focusing of the child's attention on their hair loss, which may result from active treatment, have to be weighed carefully against the potential benefits. On the other hand, some patients are appreciative that something has been tried, even if it does not work.

Definition of alopecia - NCI Dictionary of Cancer Terms
The lack or loss of hair from areas of the body where hair is usually found. Alopecia can be a side effect of some cancer treatments.

Alopecia Areata Registry - Full Text View - ClinicalTrials.gov
Alopecia areata is a condition in which hair is lost either from part of the scalp, all of the scalp, or the entire body, and it affects 1% to 2% of the population. It is thought to be an autoimmune disease and in some cases the disease is hereditary. The Alopecia Areata Registry will collect information and blood samples from clinically well-characterized patients with these three forms of Alopecia areata: Alopecia partialis (patchy loss of the scalp hair), Alopecia totalis (total loss of all scalp hair), and Alopecia universalis (complete loss of all hair everywhere on the body). This will be a collection of patients in multi-generational families, twins, single patients with patchy, persistent transient Alopecia areata or long-standing Alopecia totalis/ universalis and with controls (persons unaffected and not related to Alopecia patients). Information from these patients will be used to search the human genome for disease-associated loci and/ or genes. Researchers interested in doing pathophysiology or treatment studies of this disease will also be able to contact patients having the appropriate form of the disease for the studies in question.

MedlinePlus Interactive Tutorials: Alopecia
MedlinePlus Interactive Tutorials: Alopecia

FCIC: Questions and Answers About Alopecia Areata
The key to coping is valuing yourself for who you are, not for how much hair you have or don't have. Many people learning to cope with Alopecia areata find it helpful to talk with other people who are dealing with the same problems. More than four million people nationwide have this disease at some point in their lives, so you are not alone. If you would like to be in touch with others with the disease, the National Alopecia Areata Foundation (NAAF) can help through its pen pal program, message boards, annual conference, and support groups that meet in various locations nationwide. To find contact information for NAAF and other organizations that can help people with Alopecia areata, see "Where Can I Learn More About Alopecia Areata?" .

Search Results - THOMAS (Library of Congress)
`(p)(1) A contract may not be made or a plan approved which does not include coverage for scalp hair prosthesis (which may include artificial substitutes for scalp hair) for an individual who has scalp hair loss as a result of Alopecia areata if the attending physician of the individual certifies in writing the medical necessity of that proposed course of rehabilitative treatment.

Cancer.gov - Error
Cancer.gov - Error

Fortnightly review: Male pattern androgenetic alopecia
Fortnightly review: Male pattern androgenetic Alopecia

healthfinder.gov — Cicatricial Alopecia Research Foundation - C.A.R.F.
The Cicatricial Alopecia Research Foundation (C.A.R.F.) is the world s only organization and voice for patients and families with cicatricial Alopecia. Cicatricial or scarring Alopecia comprises a group of rare disorders that cause permanent destruction of the hair follicle. These disorders are difficult to treat and cause permanent hair loss, often with much pain, itching and burning. Patients describe their symptoms as hair on fire .

Guidelines for the management of alopecia areata.
An explanation of Alopecia areata, including discussion of the nature and course of the disease and the available treatments, is essential. Some patients are profoundly upset by their Alopecia and may require psychological support. Contact with other sufferers and patient support groups may help patients adjust to their disability. The decision to treat Alopecia areata actively should not be taken lightly. Treatment can be uncomfortable for the patient, time consuming and potentially toxic. It may also alter the patient's attitude to their hair loss. Some patients find it difficult to cope with relapse following or during initially successful treatment and they should be forewarned of this possibility. These considerations are particularly important in children where the social disruption and focusing of the child's attention on their hair loss, which may result from active treatment, have to be weighed carefully against the potential benefits. On the other hand, some patients are appreciative that something has been tried, even if it does not work.

Alopecia areata
The Online Mendelian Inheritance in Man (OMIM) database contains genetics resources that discuss Alopecia areata. Click on the link to go to OMIM and review these resources.

Systemic corticosteroids in alopecia totalis
Systemic corticosteroids in Alopecia totalis

Congenital alopecia X-linked
The Online Mendelian Inheritance in Man (OMIM) database contains genetics resources that discuss Congenital Alopecia X-linked. Click on the link to go to OMIM and review these resources.

NIH News Release--National Registry Established for Alopecia Areata- - 02/20/2001
Registry scientists will seek out and classify medical and family history data for patients with three major forms of Alopecia areata: Alopecia areata (patchy scalp hair loss); Alopecia totalis (100 percent scalp hair loss); and Alopecia universalis (100 percent scalp and 100 percent body hair loss). Families with multiple affected members will be especially helpful to further research studies. The project will offer a future central information source where researchers can obtain statistical data associated with the disease. A Web site is currently being developed for the registry.

Search of: Open Studies | "Alopecia" - List Results - ClinicalTrials.gov
Alopecia Areata; Alopecia Totalis; Alopecia Universalis; Autoimmune Hair Loss; Alopecia Partialis

Copyright (c), GovHealthInfo.com. All rights reserved. Unauthorized duplication or redistribution strictly prohibited. Created on Saturday, June 07, 2008

Disclaimer: This product is a private information resource with no affiliation whatsoever to any agency or entity within the U.S Government. This product and all related content and functionality are provided "as is" without warranty of any kind, either express or implied, including, without limitation, the implied warranties of merchantability or fitness for a particular purpose. The entire risk arising out of use or performance of this product remains with you. Use at your own risk. Under no circumstances will the owner of this site be liable for any of the content placed by any individual on any portion of this site. Please check with your doctor for expert professional assistance in diagnosing or treating any disease or illness.